Hirokazu Komatsu

Nagoya, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 145 publications

An Analysis of Four Patients Discontinuing Idecabtagene Vicleucel after Leukapheresis due to Multiple Myeloma Progression.

An Analysis of Four Patients Discontinuing Idecabtagene Vicleucel after Leukapheresis due to Multiple Myeloma Progression.

Journal: Internal medicine (Tokyo, Japan)

Published: January 04, 2026

Refining the simplified frailty scale to improve the risk stratification of patients with multiple myeloma.

Refining the simplified frailty scale to improve the risk stratification of patients with multiple myeloma.

Journal: Journal of geriatric oncology

Published: November 01, 2025

Continuation of atezolizumab plus bevacizumab beyond initial progressive disease: clinical benefits in patients with unresectable hepatocellular carcinoma - a multicenter cohort study.

Continuation of atezolizumab plus bevacizumab beyond initial progressive disease: clinical benefits in patients with unresectable hepatocellular carcinoma - a multicenter cohort study.

Journal: Frontiers in immunology

Published: June 25, 2025

Amrubicin monotherapy for refractory, relapsed, small cell lung cancer in elderly patients.

Amrubicin monotherapy for refractory, relapsed, small cell lung cancer in elderly patients.

Journal: Japanese journal of clinical oncology

Published: June 01, 2025

Targeting Overexpressed IDO in Stromal Cells as a Potential Therapeutic Strategy in Multiple Myeloma.

Targeting Overexpressed IDO in Stromal Cells as a Potential Therapeutic Strategy in Multiple Myeloma.

Journal: Cancer science

Published: March 19, 2025

Prevalence of CCR7-Positive CD8 T Cells as a Prognostic Factor in B-Cell Maturation Antigen -Targeted Chimeric Antigen Receptor T Cell Therapy.

Prevalence of CCR7-Positive CD8 T Cells as a Prognostic Factor in B-Cell Maturation Antigen -Targeted Chimeric Antigen Receptor T Cell Therapy.

Journal: EJHaem

Published: February 20, 2025

Impact of MYD88 and/or CD79B mutations on central nervous system relapse in patients with diffuse large B-cell lymphoma.

Impact of MYD88 and/or CD79B mutations on central nervous system relapse in patients with diffuse large B-cell lymphoma.

Journal: British journal of haematology

Published: January 07, 2025

Microkinetic Model to Rationalize the Lifetime of Electrocatalysis: Trade-off between Activity and Stability.

Microkinetic Model to Rationalize the Lifetime of Electrocatalysis: Trade-off between Activity and Stability.

Journal: The journal of physical chemistry letters

Published: September 30, 2024

Immunosuppressive Effects of Multiple Myeloma-Derived Extracellular Vesicles Through T Cell Exhaustion.

Immunosuppressive Effects of Multiple Myeloma-Derived Extracellular Vesicles Through T Cell Exhaustion.

Journal: Cancer science

Published: August 26, 2024

A case of R0 resection in conversion surgery after duodenal stent placement for locally advanced unresectable pancreatic cancer with duodenal stenosis

A case of R0 resection in conversion surgery after duodenal stent placement for locally advanced unresectable pancreatic cancer with duodenal stenosis

Journal: Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology

Published: May 12, 2024

COVID-19 in patients receiving treatment at an outpatient chemotherapy unit.

COVID-19 in patients receiving treatment at an outpatient chemotherapy unit.

Journal: Japanese journal of clinical oncology

Published: April 22, 2024

Fulminant hepatitis in a hepatitis B surface antigen-positive patient with adult T-cell leukemia-lymphoma after mogamulizumab monotherapy.

Fulminant hepatitis in a hepatitis B surface antigen-positive patient with adult T-cell leukemia-lymphoma after mogamulizumab monotherapy.

Journal: Hepatology research : the official journal of the Japan Society of Hepatology

Published: February 17, 2024

Showing 1-12 of 145

Last Updated: 09/26/2026